Innate Pharma to participate in the Kempen Life Sciences conference
Innate Pharma Files Its 2025 Universal Registration Document (Document D’enregistrement Universel) And 2025 Form 20-f Annual Report
Innate Pharma reports full year 2025 financial results and business update
Innate Pharma announces conference call and webcast for full year 2025 financial results
Number of shares and voting rights of Innate Pharma as of February 19, 2026
Innate pharma to participate in the Leerink Partners Global Healthcare Conference
Number of shares and voting rights of Innate Pharma as of December 31, 2025
Number of shares and voting rights of Innate Pharma as of December 18, 2025
Innate Pharma releases its 2026 financial calendar
Number of shares and voting rights of Innate Pharma as of November 27, 2025
